Stoptions.aiStoptions.aiStoptions.aiStoptions.aiStoptions.ai
Powered by Amora Edge
How it worksResultsPricingMeet StoptieCompareBlog
Sign InStart Free Trial
Stoptions.ai
Powered by Amora Edge

Algorithmic scanning across the S&P 500 & Nasdaq 100. Stock & Options trade cards in your inbox by 9:35 AM ET every trading day.

Product
  • How it works
  • The Algorithm
  • Ticker Setups
  • Pricing
  • Morning Brief
  • Results
  • Compare tools
Account
  • Sign In
  • Start Free Trial
  • Give a gift
  • Dashboard
  • Settings
Company
  • About
  • Contact
  • Support
  • Blog
  • Sitemap
Legal
  • Terms of service
  • Privacy policy
  • Risk disclosure
  • Unsubscribe

© 2026 Stoptions.ai · All Rights Reserved

Not financial advice. Algo-generated setups are not personalised investment advice. Options trading involves significant risk of loss — past performance does not guarantee future results.

Chat with Stoptie
Stoptions.ai›Tickers›MDT
Last updated: Fri May 15, 2026 · 9:31 AM ET
↻ Next update: Thu, May 21, 2026 · 9:31 AM ET

MDTStock and Options Trade Setup — Medtronic plcMDT logo

NYSE · Healthcare (Medical Devices — Diversified) · High-liquidity options · Large cap · ~$110B

▲ Bullish setupHealthcareMedical DevicesDividend AristocratLow risk↑ Score +4 vs last update
68
Amora Edge Score
68
Top 23% of today's scan
↑ +4 vs last update
Composite of EMA, RSI, RS vs SPY & volume · updated every 72h
64
MDT Win Rate
64%
13 of 20 MDT setups hit target in 2025-2026
Tracks completed Stoptions setups on this ticker since Jan 2026
Why we cover MDT

Medtronic is in the middle of a multi-year R&D harvest cycle. After years of underwhelming organic growth and operational missteps, the pipeline is delivering: Hugo robotic surgery platform launching commercially in 2026 (challenger to Intuitive Surgical), Symplicity Spyral renal denervation gaining commercial momentum for resistant hypertension treatment, MiniMed 780G insulin pump continuing diabetes share gains, and pulse-field ablation (PFA) catheters opening a new $5B+ atrial fibrillation TAM. The CEO transition to Geoffrey Martha's successor in 2026 is a watch-item but the strategy is established. Margins are expanding as portfolio rationalisation (divesting lower-margin businesses) compounds. Dividend has been increased for 46+ consecutive years (Dividend Aristocrat). Beta is among the lowest in med-tech. Risk profile is low. Options liquidity is high; medium-duration directional setups around product launch catalysts have been productive.

Score History & Signal Changelog

Preview data

This page is updated every 72 hours with the latest Scan results. Each data point below represents one complete algorithmic snapshot in time.

Score progression across 4 updates
Solid = composite · dashed = components
Signal Changelog
DateUpdateScoreDeltaKey change
May 1#1 Created58—Page created. Q1 organic growth +5%; Hugo commercial launch milestones met.
May 5#2 Update61+3EMA structure constructive. Symplicity Spyral early adoption positive.
May 10#3 Update64+3RS rank improving vs med-tech peers. PFA share gains.
May 15#4 Current68+4All four signals Active. Product cycle harvest thesis intact.

Signal Breakdown

EMA Cross
Active
17/25
21-day EMA above 50-day; trend slope steady
RSI Zone
Active
17/25
RSI at 60 — supportive momentum, room to run
RS vs SPY
Active
17/25
Outperforming SPY +2.8pp; med-tech cohort leader
Volume Surge
Active
17/25
1.3x 20-day average on advance days; institutional accumulation

Today's Trade Card

Setup
MDT $95 CALL
Expires Jul 18, 2026
Premium
$2.40
Target
+55% premium
Stop loss
-35% premium
Breakeven
$97.4
Win prob.
58%
Sizing: Risk <= 1% of account
Greeks
Delta
0.46
Theta
-0.04
IVR
22%
IVR class
Low
Trade card available on Pro & Elite
Or Start Free Trial →

Options Profile

Avg IV (30d)
22%
IVR range (52-wk)
12-42%
Put/call ratio
0.66
Avg daily vol.
22K contracts
Open interest
320K contracts
Next earnings
Aug 19, 2026 (est.)

Risks & Fundamentals

Every setup carries risk. Here's what could move MDT against you, plus the key stats that frame any position.

Beta
0.8
Market cap
~$110B
Risk level
Low risk
Next earnings
Aug 19, 2026 (est.)
Key risks to monitor
  • 1.Hugo robotic surgery slower commercial ramp vs Intuitive da Vinci entrenched base
  • 2.Renal denervation reimbursement pace slower than modelled in U.S. and Europe
  • 3.Generative AI / diagnostic device disruption emerging in cardiac monitoring
These are real risks to the long thesis, not a recommendation to short. Stoptions setups are short-dated and stop-protected; size accordingly.

MDT Options Setup — Frequently Asked Questions

Is MDT a good options trade today?+

Medtronic plc (MDT) currently has an Amora Edge Score of 68/100, ranking it top 23% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.

What is MDT's win rate on Stoptions.ai setups?+

MDT's historical win rate on closed Stoptions setups is 64%. Win rate is calculated as the percentage of past MDT trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.

What strike and expiry does Stoptions.ai suggest for MDT?+

The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.

How often is the MDT setup updated?+

Every 72 hours we refresh MDT's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If MDT drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.

What does the Amora Edge Score measure for MDT?+

The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to MDT: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is MDT outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. MDT currently scores 68.

How does MDT compare to other Healthcare (Medical Devices — Diversified) setups?+

MDT's sector rank and percentile against other Healthcare (Medical Devices — Diversified) tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Healthcare (Medical Devices — Diversified) Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.

Educational content only — not personalized investment advice. Options carry substantial risk.

The Weekly · Free

Get a Friday Recap Including Setups Like MDT.

Every Friday at 4:30 PM ET — Trade of the Week, Signal Movement, Sector Spotlight, Technical Analysis, and more. A 4-minute read. Free.

No spam. One email Friday afternoon. Unsubscribe in one click.

More from Stoptions.ai
← All tickersHow the algorithm worksMorning BriefResultsPricing